tradingkey.logo

InfuSystem Holdings Inc

INFU
9.160USD
-0.040-0.43%
收盘 12/22, 16:00美东报价延迟15分钟
186.20M总市值
34.59市盈率 TTM

InfuSystem Holdings Inc

9.160
-0.040-0.43%

关于 InfuSystem Holdings Inc 公司

InfuSystem Holdings, Inc. is a national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.

InfuSystem Holdings Inc简介

公司代码INFU
公司名称InfuSystem Holdings Inc
上市日期Jun 15, 2006
CEOLachance (Carrie A)
员工数量502
证券类型Ordinary Share
年结日Jun 15
公司地址3851 West Hamlin Road
城市ROCHESTER HILLS
上市交易所NASDAQ OMX – NASDAQ Basic Amex
国家United States of America
邮编48309
电话12482911210
网址https://ir.infusystem.com/
公司代码INFU
上市日期Jun 15, 2006
CEOLachance (Carrie A)

InfuSystem Holdings Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Addam Chupa
Mr. Addam Chupa
Executive Vice President, Chief Information Officer
Executive Vice President, Chief Information Officer
39.60K
+19.06%
Mr. Jerod Funke
Mr. Jerod Funke
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
18.66K
+89.83%
Mr. Kenneth D. Eichenbaum
Mr. Kenneth D. Eichenbaum
Independent Director
Independent Director
6.00K
+50.00%
Ms. Beverly A. Huss
Ms. Beverly A. Huss
Independent Director
Independent Director
4.00K
-6.98%
Ms. Carrie A. Lachance
Ms. Carrie A. Lachance
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Paul A. Gendron
Mr. Paul A. Gendron
Independent Director
Independent Director
--
--
Mr. Joe Dorame
Mr. Joe Dorame
Investor Relations
Investor Relations
--
--
Mr. Scott A. Shuda, J.D.
Mr. Scott A. Shuda, J.D.
Director
Director
--
--
Mr. Ronald (Ron) Hundzinski
Mr. Ronald (Ron) Hundzinski
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Barry G. Steele
Mr. Barry G. Steele
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Addam Chupa
Mr. Addam Chupa
Executive Vice President, Chief Information Officer
Executive Vice President, Chief Information Officer
39.60K
+19.06%
Mr. Jerod Funke
Mr. Jerod Funke
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
18.66K
+89.83%
Mr. Kenneth D. Eichenbaum
Mr. Kenneth D. Eichenbaum
Independent Director
Independent Director
6.00K
+50.00%
Ms. Beverly A. Huss
Ms. Beverly A. Huss
Independent Director
Independent Director
4.00K
-6.98%
Ms. Carrie A. Lachance
Ms. Carrie A. Lachance
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Paul A. Gendron
Mr. Paul A. Gendron
Independent Director
Independent Director
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Patient Services revenue
19.28M
53.55%
Device Solutions revenue
8.95M
24.85%
Device Solutions Lease Revenue
5.54M
15.39%
Patient Services Lease Revenue
2.24M
6.22%
由于公司未披露,未能获取相关数据
业务
地区
业务USD
名称
营收
占比
Patient Services revenue
19.28M
53.55%
Device Solutions revenue
8.95M
24.85%
Device Solutions Lease Revenue
5.54M
15.39%
Patient Services Lease Revenue
2.24M
6.22%

股东统计

更新时间: 12月20日 周六
更新时间: 12月20日 周六
持股股东
股东类型
持股股东
持股股东
占比
Acuitas Investments LLC
5.06%
Minerva Advisors LLC
5.04%
The Vanguard Group, Inc.
4.80%
Sansone Advisors, LLC
4.62%
Punch & Associates Investment Management, Inc.
3.98%
其他
76.50%
持股股东
持股股东
占比
Acuitas Investments LLC
5.06%
Minerva Advisors LLC
5.04%
The Vanguard Group, Inc.
4.80%
Sansone Advisors, LLC
4.62%
Punch & Associates Investment Management, Inc.
3.98%
其他
76.50%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
35.40%
Investment Advisor
27.78%
Hedge Fund
9.26%
Individual Investor
5.12%
Research Firm
2.06%
Corporation
1.93%
Pension Fund
1.06%
Venture Capital
0.10%
Bank and Trust
0.06%
其他
17.23%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
195
15.39M
75.69%
-2.65M
2025Q2
189
17.55M
85.91%
-1.74M
2025Q1
195
17.88M
85.24%
-1.68M
2024Q4
183
18.11M
85.19%
-1.50M
2024Q3
177
18.08M
85.13%
-1.29M
2024Q2
178
19.06M
89.56%
-840.23K
2024Q1
177
19.09M
89.78%
-1.32M
2023Q4
184
19.33M
91.44%
-2.24M
2023Q3
193
19.14M
90.76%
-805.39K
2023Q2
210
18.55M
88.36%
-69.89K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Acuitas Investments LLC
1.03M
5.04%
-196.14K
-16.01%
Sep 30, 2024
Minerva Advisors LLC
994.78K
4.87%
+84.10K
+9.24%
Jun 30, 2025
The Vanguard Group, Inc.
957.64K
4.69%
-122.64K
-11.35%
Jun 30, 2025
Sansone Advisors, LLC
939.29K
4.6%
-204.00K
-17.84%
Jan 21, 2025
Punch & Associates Investment Management, Inc.
878.50K
4.3%
+263.84K
+42.93%
Jun 30, 2025
First Eagle Investment Management, L.L.C.
910.37K
4.46%
-10.00K
-1.09%
Jun 30, 2025
Renaissance Technologies LLC
459.61K
2.25%
+124.99K
+37.35%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
564.81K
2.77%
+52.24K
+10.19%
Jun 30, 2025
AWM Investment Company, Inc.
1.27M
6.23%
-353.98K
-21.77%
Jun 30, 2025
Dilorio (Richard)
485.99K
2.38%
+21.40K
+4.61%
May 17, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Micro-Cap ETF
0.04%
Avantis US Small Cap Equity ETF
0.02%
WisdomTree US SmallCap Fund
0.02%
Avantis US Small Cap Value ETF
0.01%
ProShares Hedge Replication ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
iShares Russell 2000 Growth ETF
0%
Franklin US Small Cap Multifactor Index ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Proshares Ultra Russell 2000
0%
查看更多
iShares Micro-Cap ETF
占比0.04%
Avantis US Small Cap Equity ETF
占比0.02%
WisdomTree US SmallCap Fund
占比0.02%
Avantis US Small Cap Value ETF
占比0.01%
ProShares Hedge Replication ETF
占比0%
DFA Dimensional US Sustainability Core 1 ETF
占比0%
iShares Russell 2000 Growth ETF
占比0%
Franklin US Small Cap Multifactor Index ETF
占比0%
Global X Russell 2000 Covered Call ETF
占比0%
Proshares Ultra Russell 2000
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

InfuSystem Holdings Inc的前五大股东是谁?

InfuSystem Holdings Inc 的前五大股东如下:
Acuitas Investments LLC持有股份:1.03M,占总股份比例:5.04%。
Minerva Advisors LLC持有股份:994.78K,占总股份比例:4.87%。
The Vanguard Group, Inc.持有股份:957.64K,占总股份比例:4.69%。
Sansone Advisors, LLC持有股份:939.29K,占总股份比例:4.60%。
Punch & Associates Investment Management, Inc.持有股份:878.50K,占总股份比例:4.30%。

InfuSystem Holdings Inc的前三大股东类型是什么?

InfuSystem Holdings Inc 的前三大股东类型分别是:
Acuitas Investments LLC
Minerva Advisors LLC
The Vanguard Group, Inc.

有多少机构持有InfuSystem Holdings Inc(INFU)的股份?

截至2025Q3,共有195家机构持有InfuSystem Holdings Inc的股份,合计持有的股份价值约为15.39M,占公司总股份的75.69%。与2025Q2相比,机构持股有所增加,增幅为-10.22%。

哪个业务部门对InfuSystem Holdings Inc的收入贡献最大?

在FY2025Q2,Patient Services revenue 业务部门对InfuSystem Holdings Inc的收入贡献最大,创收19.28M,占总收入的53.55%。
KeyAI